FRESH-PEF175-en
Study of PROXimology in seveRe persistent Asthma
PROXAIR
| Name | Country code |
|---|---|
| France | fr |
['Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Pulmonary medicine | health theme |
| Asthma | cim-11 |
{
"level_sex_clusion_I": [
{
"value": "Male",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008297"
}
},
{
"value": "Female",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D005260"
}
}
],
"level_age_clusion_I": [
{
"value": "Young Adult (19 to 24 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D055815"
}
},
{
"value": "Adult (25 to 44 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000328"
}
},
{
"value": "Middle Aged (45 to 64 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008875"
}
},
{
"value": "Aged (65 to 79 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000368"
}
}
],
"level_type_clusion_I": [
"General population"
],
"level_type_clusion_other": "",
"clusion_I": "Patient inclusion Criteria : - Ambulatory patients, able to cooperate, of either sex, at least 18 years of age. ",
"clusion_E": "micronized forms in metered-dose inhalers,≥800 µg\/d of beclometasone dipropionate in micronized form in metered-dose inhalers or ≥800 µg\/j of budesonide or ≥500 µg\/d of fluticasone propionate) and of inhaled long-acting ß2 agonists, administered:either in the form of two specialties using one or two of the following inhalers: Aerolizer®, standard metered-dose inhaler, Autohaler, Diskus®, Turbuhaler®,or in the form of a fixed association using one of the following inhalers: standard metered-dose inhaler, Diskus®, Turbuhaler®. - Patients with FEV measurement in the previous month. - Patients who brought their inhaled steroid treatment and inhaled long-acting ß2-agonist at the time of consultation. - Patients in couple whether or not married - Patients and relatives agree to participatePatientCriteria :- Patients with a non-asthmatic OCPD. - Patients who had inhaled steroids or lLABA treatment change in the previous three months (add-on or change of drug, posology change). - Patients and relatives refusing to participate to the study - Parents\/ those close unable to complete a self-questionnaire. - Patients who do not live as a couple"
}
| Name |
|---|
| Anne;PONTHIEUX |
| Name | Role |
|---|---|
| NOVARTIS PHARMA SAS | sponsor |
| Name |
|---|
| NOVARTIS PHARMA SAS |
['Through independent healthcare practitioners']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2006-01-01 | 2007-01-01 |
One-time cross-sectional study
| Standard |
|---|
| ['GINA classification'] |
{"value":"To be defined","extLink":[]}
| Name | |
|---|---|
| Anne;PONTHIEUX | anne.ponthieux@novartis.com |
FRESH-PEF175-en
| Name | Affiliation |
|---|---|
| Anne PONTHIEUX | NOVARTIS PHARMA SAS |